ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,171Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 247

$642K Total Retail Price of All Prescriptions

Rank: 18 out of 247

436 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 436 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 436 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,337 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 492 312 1 1
LEVOTHYROXINE SODIUM 408 278 2 3
LISINOPRIL 402 255 3 2
WARFARIN SODIUM 401 168 4 13
ATORVASTATIN CALCIUM 276 205 5 8
METFORMIN HCL 267 164 6 12
OMEPRAZOLE 262 128 7 4
FUROSEMIDE 251 169 8 5
BACLOFEN 231 50 9 104
GABAPENTIN 216 113 10 17
ATENOLOL 215 156 11 10
HYDROCHLOROTHIAZIDE 198 140 12 9
TRAZODONE HCL 187 98 13 28
METOPROLOL SUCCINATE 171 139 14 14
METOPROLOL TARTRATE 162 104 15 7
CITALOPRAM HBR 155 58 16 20
AMLODIPINE BESYLATE 151 119 17 6
CYMBALTA 142 49 18 52
TRAMADOL HCL 122 59 19 25
SERTRALINE HCL 120 66 20 16
MIRTAZAPINE 120 100 20 46
RANITIDINE HCL 104 50 22 34
RISPERIDONE 100 26 23 58
TAMSULOSIN HCL 99 83 24 31
ALENDRONATE SODIUM 95 65 25 32
CARBAMAZEPINE 95 0 25 177
GLIPIZIDE 94 53 27 43
LEVETIRACETAM 93 0 28 153
LIDODERM 86 59 29 74
LANTUS 85 15 30 39
ADVAIR DISKUS 83 45 31 18
DONEPEZIL HCL 81 81 32 35
AZITHROMYCIN 78 54 33 48
HYDROCODONE-ACETAMINOPHEN 75 41 S3 34 11
KLOR-CON M20 74 57 35 44
DIOVAN 74 67 35 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 35 37 138
FAMOTIDINE 73 0 37 66
OLANZAPINE 72 31 39 106
PREDNISONE 71 40 40 21
SPIRONOLACTONE 70 46 41 53
OXYCODONE HCL 69 26 S2 42 27
CYCLOBENZAPRINE HCL 67 0 R 43 54
CRESTOR 66 38 44 30
DIVALPROEX SODIUM 65 30 45 117
LOVASTATIN 64 52 46 22
COMBIVENT 63 27 47 63
PANTOPRAZOLE SODIUM 63 45 47 19
NEXIUM 62 43 49 42
PROAIR HFA 62 25 49 29
QUETIAPINE FUMARATE 62 0 49 84
FLUOXETINE HCL 61 40 52 49
FLUTICASONE PROPIONATE 60 33 53 37
ALLOPURINOL 59 47 54 33
POTASSIUM CHLORIDE 58 30 55 36
POLYETHYLENE GLYCOL 3350 56 26 56 77
SPIRIVA 55 31 57 26
ZOSTAVAX 54 54 58 59
AMITRIPTYLINE HCL 52 22 R 59 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.